{
    "text": "<p>*** These articles are required reading, and are of particular importance and interest. Graduate students are responsible for <strong>all</strong> articles.</p> <h2 class=\"subhead\">Required Text</h2> <p><a href=\"http://www.amazon.com/exec/obidos/ASIN/0195140087/ref=nosim/mitopencourse-20\"><img alt=\"Buy at Amazon\" src=\"/images/a_logo_17.gif\" align=\"absMiddle\" border=\"0\" /></a> Cooper, Jack R., Floyd E. Bloom, and Robert H. Roth. <em>The Biochemical Basis of Neuropharmacology</em>. 8th ed. Oxford, UK: Oxford University Press, 2002. ISBN: 9780195140088.</p> <div class=\"maintabletemplate\"><table summary=\"See table caption for summary.\"> <caption class=\"invisible\">Course readings.</caption> <thead> <tr> <th scope=\"col\">SES&nbsp;#</th> <th scope=\"col\">TOPICS</th> <th scope=\"col\">READINGS</th> </tr> </thead> <tbody> <tr class=\"row\"> <td>1</td> <td>Neurotransmitters, receptors, and actions</td> <td><p>Cooper, Bloom, and Roth. &quot;Introduction.&quot; Chapter 1, pp. 1-6.</p> <p>&mdash;&mdash;&mdash;. &quot;Cellular Foundations of Neuropharmacology.&quot; Chapter 2, pp. 7-37.</p> <p>&mdash;&mdash;&mdash;. &quot;Molecular Foundations of Neuropharmacology.&quot; Chapter 3, pp. 39-64.</p> <p>*** Funk, C. D. &quot;Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology.&quot; <em>Science</em> 294 (2001): 1871-1875.</p> <p>*** Corbin J. D., S. H. Francis, and D. J. Webb. &quot;Phosphodiesterase Type 5 as a Pharmacologic Target in Erectile Dysfunction.&quot; <em>Urology</em> 60, 2, Suppl. 2 (2002): 4-11.</p> <p>Moncada, S., and A. Higgs. &quot;The L-Arginine-Nitric Oxide Pathway.&quot; <em>N Engl J Med</em> 329, no. 27 (1993): 2002-2012.</p> <p>Snyder, S. H., and G. W. Pasternak. &quot;Historical Review: Opioid Receptors.&quot; <em>Trends Pharmacol Sci</em> 24, no. 4 (April 2003): 198-205.</p></td> </tr> <tr class=\"alt-row\"> <td>2</td> <td>Membranes and the blood brain barrier</td> <td><p><a href=\"http://www.amazon.com/Basic-Neurochemistry-Molecular-Cellular-Periodicals/dp/039751820X/ref=sr_11_1?ie=UTF8&amp;qid=1206612689&amp;sr=11-1\"><img alt=\"Buy at Amazon\" src=\"/images/a_logo_17.gif\" align=\"absMiddle\" border=\"0\" /></a> *** Laterra, J., R. Keep, L. A. Betz, and G. W. Goldstein. &quot;Blood-Brain Barrier.&quot; In <em>Basic Neurochemistry: Molecular, Cellular, and Medical Aspects</em>. Edited by George J. Siegel, Bernard W. Agranoff, R. Wayne Albers, Stephen K. Fisher, and Michael D. Uhler. Baltimore, MD: Lippincott Williams &amp; Wilkins, c1999. ISBN: 9780397518203.</p> <p><a href=\"http://www.amazon.com/Determinants-Availability-Nutrients-Brain-Nutrition/dp/0890040451/ref=sr_11_1?ie=UTF8&amp;qid=1206613864&amp;sr=11-1\"><img alt=\"Buy at Amazon\" src=\"/images/a_logo_17.gif\" align=\"absMiddle\" border=\"0\" /></a> *** Pardridge, W. M. &quot;Regulation of Amino Acid Availability to the Brain.&quot; In <em>Nutrition and the Brain</em>. Vol. 1. Edited by R. J. Wurtman and J. J. Wurtman. New York, NY: Raven Press, 1977, pp. 142-175. ISBN: 9780890040454.</p> <p>*** Wurtman, R. J., et al. &quot;Synaptic Proteins and Phospholipids are Increased in Gerbil Brain by Administering Uridine Plus DHA Orally.&quot; <em>Brain Research</em> 1088 (2006): 83-92.</p> <p>Kang, J. X., et al. &quot;<em>Fat-1</em> Mice Convert <em>n</em>-6 to <em>n</em>-3 Fatty Acids.&quot; <em>Nature</em> 427 (2004): 504.</p> <p>Pooler, A., et al. &quot;Uridine Enhances Neurite Outgrowth in NGF-Differentiated PC-12 Cells.&quot; <em>Neuroscience</em> 134 (2005): 207-214.</p></td> </tr> <tr class=\"row\"> <td>3</td> <td>Acetylcholine: biochemistry</td> <td><p>Cooper, Bloom, and Roth. &quot;Acetylcholine.&quot; Chapter 7, pp. 151-179.</p> <p>*** Ulus, I. H., R. J. Wurtman, C. Mauron, and J. K. Blusztajn. &quot;Choline Increases Acetylcholine Release and Protects Against the Stimulation-Induced Decrease in Phosphatide Levels within Membranes of Rat Corpus Striatum.&quot; <em>Brain Research</em> 484 (1989): 217-227.</p> <p>Wurtman, Cansev, and Ulus. &quot;Choline and Its Products, Acetylcholine, and Phosphatidylcholine.&quot; <em>Handbook of Neurochemistry,</em> 2007, pp. 3-38.</p></td> </tr> <tr class=\"alt-row\"> <td>4</td> <td>Acetylcholine: Alzheimer's disease</td> <td><p>Cooper, Bloom, and Roth. &quot;Treating Neurological and Psychiatric Diseases.&quot; Chapter 13, pp. 373-400.</p> <p>*** Selkoe, D. J. &quot;Alzheimer's Disease is a Synaptic Failure.&quot; <em>Science</em> 298 (2002): 789-791.</p> <p>Nitsch R. M., J. K. Blusztajn, A. G. Pittas, B. E. Slack, J. H. Growdon, and R. J. Wurtman. &quot;Evidence for a Membrane Defect in Alzheimer Disease.&quot; <em>Brain Proc Natl Acad Sci USA</em> 89 (1992): 1671-1675.</p> <p>Tuszynski, M. H., L. Thal, M. Pay, D. P. Salmon, U HS, R. Bakay, P. Patel, A. Blesch, H. L. Vahlsing, Ho G, G. Tong, S. G. Potkin, J. Fallon, L. Hansen, E. J. Mufson, J. H. Kordower, C. Gall, and J. Conner. &quot;A Phase 1 Clinical Trial of Nerve Growth Factor Gene Therapy for Alzheimer Disease.&quot; <em>Nat Med</em> 11, no. 5 (May 2005): 551-555.</p></td> </tr> <tr class=\"row\"> <td>5</td> <td>Dopamine: biochemistry and Parkinson's disease</td> <td><p>Cooper, Bloom, and Roth. &quot;Dopamine.&quot; Chapter 9, pp. 225-270.</p> <p>&mdash;&mdash;&mdash;. &quot;Treating Neurological and Psychiatric Diseases.&quot; Chapter 13, pp. 373-400.</p> <p>*** Hokfelt, T., J. F. Rehfeld, L. Skirboll, B. Ivemark, M. Goldstein, and K. Markey. &quot;Evidence for Coexistence of Dopamine and CCK in Meso-Limbic Neurones.&quot; <em>Nature</em> 285 (1980): 476-477.</p> <p>*** Burns, R. S., P. A. LeWitt, M. H. Ebert, H. Pakkenberg, and I. J. Kopin. &quot;The Clinical Syndrome of Striatal Dopamine Deficiency.&quot; <em>N Engl J Med</em> 312, no. 22 (1985): 1418-1421.</p> <p>*** Acworth, I. N., M. J. During, and R. J. Wurtman. &quot;Tyrosine: Effects on Catecholamine Release.&quot; <em>Brain Res Bull</em> 21, no. 3 (1988): 473-477.</p> <p>Bezard, E., S. Ferry, U. Mach, H. Stark, L. Leriche, T. Boraud, C. Gross, and P. Sokoloff. &quot;Attenuation of Levodopa-Induced Dyskinesia by Normalizing Dopamine D(3) Receptor Function.&quot; <em>Nat Med</em> 9, no. 6 (2003): 762-767.</p> <p>Knecht, S., C. Breitenstein, S. Bushuven, S. Wailke, S. Kamping, A. Floel, P. Zwitserlood, and E. B. Ringelstein. &quot;Levodopa: Faster and Better Word Learning in Normal Humans.&quot; <em>Ann Neurol</em> 56, no. 1 (July 2004): 20-26.</p> <p>Cansev, M., and R. J. Wurtman. &quot;Aromatic Amino Acids.&quot; In <em>Handbook of Neurochemistry and Molecular Neurobiology</em>. Vol. 6, chapter 3, 2006, pp. 60-97.</p></td> </tr> <tr class=\"alt-row\"> <td>6</td> <td>Norepinephrine and epinephrine</td> <td><p>Cooper, Bloom, and Roth. &quot;Norepinephrine and Epinephrine.&quot; Chapter 8, pp. 181-223.</p> <p>&mdash;&mdash;&mdash;. &quot;Treating Neurological and Psychiatric Diseases.&quot; Chapter 13, pp. 373-400.</p> <p>*** Wurtman, R. J., and J. Axelrod. &quot;Control of Enzymatic Synthesis of Adrenaline in the Adrenal Medulla by Adrenal Cortical Steroids.&quot; <em>J Biol Chem</em> 241, no. 10 (1966): 2301-2305.</p> <p>*** Berridge, C. W., and B. D. Waterhouse. &quot;The Locus Coeruleus-Noradrenergic System: Modulation of Behavioral State and State-Dependent Cognitive Processes.&quot; <em>Brain Res Rev</em> 42 (2003): 33-84.</p> <p>Insel, P. A. &quot;Adrenergic Receptors-Evolving Concepts and Clinical Implications.&quot; <em>N Engl J Med</em> 334, no. 9 (1996): 580-585.</p> <p>Melamed, E., F. Hefti, and R. J. Wurtman. &quot;Tyrosine Administration Increases Striatal Dopamine Release in Rats with Partial Nigrostriatal Lesions.&quot; <em>PNAS</em> 77, no. 7 (1980): 4305-4309.</p> <p>Conlay, L. A., T. J. Maher, and R. J. Wurtman. &quot;Tyrosine Increases Blood Pressure in Hypotensive Rats.&quot; <em>Science</em> 212, no. 4494 (1981): 559-560.</p></td> </tr> <tr class=\"row\"> <td>7</td> <td>Serotonin: biochemistry</td> <td><p>Cooper, Bloom, and Roth. &quot;Serotonin, Histamine, and Adenosine.&quot; Chapter 10, pp. 271-304.</p> <p>&mdash;&mdash;&mdash;. &quot;Treating Neurological and Psychiatric Diseases.&quot; Chapter 13, pp. 373-400.</p> <p>*** Fernstrom, J. D., and R. J. Wurtman. &quot;Brain Serotonin Content: Physiological Dependence on Plasma Tryptophan Levels.&quot; <em>Science</em> 173 (1971): 149-152.</p> <p>*** &mdash;&mdash;&mdash;. &quot;Brain Serotonin Content: Physiological Regulation by Plasma Neutral Amino Acids.&quot; <em>Science</em> 178 (1972): 414-416.</p> <p>*** Wurtman, R. J., and J. J. Wurtman. &quot;Carbohydrates and Depression.&quot; <em>Scientific American</em> 1 (1989): 68-75.</p> <p>*** Schaechter, J. D., and R. J. Wurtman. &quot;Tryptophan Availability Modulates Serotonin Release from Rat Hypothalamic Slices.&quot; <em>J Neurochem</em> 53, no. 6 (1989): 1925-1933.</p> <p>*** Wurtman, R. J., J. J. Wurtman, M. M. Regan, J. M. McDermott, R. H. Tsay, and J. J. Breu. &quot;Effects of Normal Meals Rich in Carbohydrates or Proteins on Plasma Tryptophan and Tyrosine Ratios.&quot; <em>Am J Clin Nutr</em> 77, no. 1 (January 2003): 128-132.</p> <p>Fernstrom, J. D., and R. J. Wurtman. &quot;Brain Serotonin Content: Increase Following Ingestion of Carbohydrate Diet.&quot; <em>Science</em> 174 (1971): 1023-1025.</p></td> </tr> <tr class=\"alt-row\"> <td>8</td> <td>Serotonin: behavior, and obesity</td> <td><p>*** Nishizawa, S., C. Benkelfat, S. N. Young, M. Leyton, S. Mzengeza, C. de Montigny, P. Blier, and M. Diksic. &quot;Differences between Males and Females in Rates of Serotonin Synthesis in Human Brain.&quot; <em>Proc Natl Acad Sci USA</em> 94 (1997): 5308-5313.</p> <p>*** Austin, M. C., R. E. Whitehead, C. L. Edgar, J. E. Januaryosky, and D. A. Lewis. &quot;Localized Decrease in Serotonin Transporter-Immunoreactive Axons in the Prefrontal Cortex of Depressed Subjects Committing Suicide.&quot; <em>Neuroscience</em> 114, no. 3 (2002): 807-815.</p> <p>*** Caspi, A., K. Sugden, T. E. Moffitt, A. Taylor, I. W. Craig, H. Harrington, J. McClay, J. Mill, J. Martin, A. Braithwaite, and R. Poulton. &quot;Influence of Life Stress on Depression: Moderation by a Polymorphism in the 5-HTT Gene.&quot; <em>Science</em> 301, no. 5631 (2003): 386-389.</p> <p>*** Fava, M., and K. S. Kendler. &quot;Major Depressive Disorder.&quot; <em>Neuron</em> 28, no. 2: 335-341.</p> <p>Zhang, X., R. R. Gainetdinov, J. M. Beaulieu, T. D. Sotnikova, L. H. Burch, R. B. Williams, D. A. Schwartz, K. R. Krishnan, and M. G. Caron. &quot;Loss-of-Function Mutation in Tryptophan Hydroxylase-2 Identified in Unipolar Major Depression.&quot; <em>Neuron</em> 45, no. 1 (January 6, 2005): 11-16.</p> <p>&quot;Zelnorm gets US FDA OK for Chronic Constipation.&quot; <em>SCRIP</em> (August 27, 2004).</p> <p>&quot;The Link Between Ecstasy, Depression and Genetics.&quot; <em>The Economist</em> (March 21, 2005).</p> <p>Wurtman, J. J., and R. J. Wurtman. &quot;<em>D</em>-Fenfluramine Selectively Decreases Carbohydrate But Not Protein Intake in Obese Subjects.&quot; <em>Intl J Obesity</em> 8, no. 1 (1984): 79-84.</p> <p>Meltzer, H. &quot;Illuminating the Molecular Basis for Some Antipsychotic Drug-Induced Metabolic Burden.&quot; <em>PNAS</em> 104 (2007): 3019-3020.</p></td> </tr> <tr class=\"row\"> <td>9</td> <td>Review</td> <td>&nbsp;</td> </tr> <tr class=\"alt-row\"> <td>10</td> <td>Hour examination - midterm</td> <td>&nbsp;</td> </tr> <tr class=\"row\"> <td>11</td> <td>Melatonin</td> <td><p>*** Wurtman, R. J. &quot;Melatonin.&quot; <em>Encyclopedia of Dietary Supplements,</em> 2005, pp. 457-466.</p> <p>Wurtman, R. J., J. Axelrod, and Chu E. W. &quot;Melatonin, A Pineal Substance: Effect on the Rat Ovary.&quot; <em>Science</em> 141 (1963): 277-278.</p> <p>Lynch, H. J., R. J. Wurtman, M. A. Moskowitz, M. C. Archer, and M. H. Ho. &quot;Daily Rhythm in the Human Urinary Melatonin.&quot; <em>Science</em> 187 (1975): 169-171.</p> <p>Zhdanova, I. V., R. J. Wurtman, M. M. Regan, J. A. Taylor, J. P. Shi, and O. U. Leclair. &quot;Melatonin Treatment for Age-Related Insomnia.&quot; <em>J Clin Endocrin Metab</em> 86, no. 10 (2001): 4727-4730.</p> <p>Gerdin, M. J., M. I. Masana, M. A. Rivera-Bermudez, R. L. Hudson, D. J. Earnest, M. U. Gillette, and M. L. Dubocovich. &quot;Melatonin Desensitizes Endogenous MT2 Melatonin Receptors in the Rat Suprachiasmatic Nucleus: Relevance for Defining the Periods of Sensitivity of the Mammalian Circadian Clock to Melatonin.&quot; <em>FASEB J</em> 18, no. 14 (November 2004): 1646-1656.</p> <p>Wurtman, R. J. &quot;Ramelteon: A Novel Treatment for the Treatment of Insomnia.&quot; <em>Expert RSV Neurother</em> 6 (2006): 957-964.</p></td> </tr> <tr class=\"alt-row\"> <td>12-13</td> <td>Glutamate: biochemistry, learning and toxicity</td> <td><p>Cooper, Bloom, and Roth. &quot;Molecular Foundations of Neuropharmacology.&quot; Chapter 3, pp. 59-64.</p> <p>&mdash;&mdash;&mdash;. &quot;Modulation of Synaptic Transmission.&quot; Chapter 5, pp. 85-104.</p> <p>&mdash;&mdash;&mdash;. &quot;Amino Acid Transmitters.&quot; Chapter 6, pp. 132-150.</p> <p>&mdash;&mdash;&mdash;. &quot;Cellular Mechanisms in Learning and Memory.&quot; Chapter 12, pp. 357-372.</p> <p>*** Mothet, J. P., A. T. Parent, H. Wolosker, R. O. Brady Jr., D. J. Linden, C. D. Ferris, M. A. Rogawski, and S. H. Snyder. &quot;D-Serine is an Endogenous Ligand for the Glycine Site of the N-Methyl-D-Aspartate Receptor.&quot; <em>Proc Natl Acad Science USA</em> 97, no. 9 (2000): 4926-4931.</p> <p>*** Malenka, R. C., and M. F. Bear. &quot;LTP and LTD: An Embarrassment of Riches.&quot; <em>Neuron</em> 44, no. 1 (September 30, 2004): 5-21.</p> <p>*** S\u00fcdhof, T. C. &quot;The Synaptic Vesicle Cycle Revisited.&quot; <em>Neuron</em> 28, no. 2 (2000): 317-320.</p> <p>Krystal, J. H., et al. &quot;NMDA Agonists and Antagonists as Probes of Glutamatergic Dysfunction and Pharmacotherapies in Neuropsychiatric Disorders.&quot; <em>Harvard Rev Psychiatry</em> 7 (1999): 125-143.</p> <p>Fon, E. A., and R. H. Edwards. &quot;Molecular Mechanisms of Neurotransmitter Release.&quot; <em>Muscle Nerve</em> 24, no. 5 (2001): 581-601.</p></td> </tr> <tr class=\"row\"> <td>14</td> <td>GABA: anxiety, seizures</td> <td><p>Cooper, Bloom, and Roth. &quot;Amino Acid Transmitters.&quot; Chapter 6, pp. 105-132.</p> <p>*** Gale, K., and M. J. Iadarola. &quot;Seizure Protection and Increased Nerve-Terminal GABA: Delayed Effects of GABA Transmission Inhibition.&quot; <em>Science</em> 208 (1980): 288-291.</p> <p>Wang, L., T. J. Maher, and R. J. Wurtman. &quot;Oral L-Glutamine Increases GABA Levels in Striatal Tissue and Extracellular Fluid.&quot; <em>FASB J</em> 21 (2007): 1227-1232.</p> <p>Nie, Z., P. Schweitzer, A. J. Roberts, S. G. Madamba, S. D. Moore, and G. R. Siggins. &quot;Ethanol Augments GABAergic Transmission in the Central Amygdala via CRF1 Receptors.&quot; <em>Science</em> 303, no. 5663 (March 5, 2004): 1512-1514.</p></td> </tr> <tr class=\"alt-row\"> <td>15</td> <td>Glycine and histamine</td> <td><p>Cooper, Bloom, and Roth. &quot;Serotonin, Histamine, and Adenosine.&quot; Chapter 10, pp. 304-320.</p> <p>*** Betz, H., and C. M. Becker. &quot;The Mammalian Glycine Receptor: Biology and Structure of a Neuronal Chloride Channel Protein.&quot; <em>Neurochem Int</em> 13, no. 2 (1988): 137-146.</p> <p>*** Anagnostaras, S. G., M. G. Craske, and M. S. Fanselow. &quot;Anxiety: At the Intersection of Genes and Experience.&quot; <em>Nature Neurosci</em> 2, no. 9 (1999): 780-782.</p> <p>*** Shankley, N. P., G. F. Watt, and J. W. Black. &quot;Definition and Localization of Histamine H2 Receptors.&quot; <em>Euro J Clin Investig</em> 25, no. 1 (1995): 12-18.</p> <p>Rogawski, M. A. &quot;Progesterone, Neurosteroids, and the Hormonal Basis of Catamenial Epilepsy.&quot; <em>Ann Neurol</em> 53, no. 3 (2003): 288-290.</p> <p>Simons, F. E. R., and K. J. Simons. &quot;The Pharmacology and Use of H1-Receptor-Antagonist Drugs.&quot; <em>New England J Med</em> 330, no. 23 (1994): 1663-1670.</p> <p>Masaki, T., S. Chiba, G. Yoshimichi, T. Yasuda, H. Noguchi, T. Kakuma, T. Sakata, and H. Yoshimatsu. &quot;Neuronal Histamine Regulates Food Intake, Adiposity, and Uncoupling Protein Expression in Agouti Yellow (A(y)/a) Obese Mice.&quot; <em>Endocrinology</em> 144, no. 6 (2003): 2741-2748.</p></td> </tr> <tr class=\"row\"> <td>16</td> <td>Cannabinoids and adenosine</td> <td><p>Cooper, Bloom, and Roth. &quot;Serotonin, Histamine, and Adenosine.&quot; Chapter 10, pp. 317-320.</p> <p>*** Fredholm, B. B. &quot;Adenosine Receptors in the Central Nervous System.&quot; <em>NIPS</em> 10 (1995): 122-128.</p> <p>*** Goutopoulos, A., and A. Makriyannis. &quot;From Cannabis to Cannabinergics: New Therapeutic Opportunities.&quot; <em>Pharmacol Ther</em> 95, no. 2 (2002): 103-117.</p> <p>*** Wilson, R. I., and R. A. Nicoll. &quot;Endocannabinoid Signaling in the Brain.&quot; <em>Science</em> 296, no. 5568 (2002): 678-682.</p> <p>Conlay, L. A., J. A. Conant, F. deBros, and R. J. Wurtman. &quot;Caffeine Alters Plasma Adenosine Levels.&quot; <em>Nature</em> 389 (1997): 136.</p></td> </tr> <tr class=\"alt-row\"> <td>17</td> <td>Brain peptides</td> <td><p>Cooper, Bloom, and Roth. &quot;Neuroactive Peptides.&quot; Chapter 11, pp. 321-356.</p> <p>*** Nichols, M. L., et al. &quot;Transmission of Chronic Nociception by Spinal Neurons Expressing the Substance P Receptor.&quot; <em>Science</em> 268 (1999): 1558-1561.</p> <p>*** Selmer, I-S., M. Schindler, J. P. Allen, P. P. A. Humphrey, and P.C. Emson. &quot;Advances in Understanding Neuronal Somatostatin Receptors.&quot; <em>Regulatory Peptides</em> 90 (2000): 1-18.</p> <p>*** Degen, L., D. Matzinger, J. Drewe, and C. Beglinger. &quot;The Effect of Cholecystokinin in Controlling Appetite and Food Intake in Humans.&quot; <em>Peptides</em> 22, no. 8 (2001): 1265-1269.</p> <p>Schwartz, M. W., S. C. Woods, D. Porte Jr., R. J. Seeley, and D. G. Baskin. &quot;Central Nervous System Control of Food Intake.&quot; <em>Nature</em> 404 (2000): 661-671.</p> <p>Wurtman, R. J. &quot;Narcolepsy and the Hypocretins.&quot; <em>Metabolism</em> 55 (2006): 536-539.</p></td> </tr> <tr class=\"row\"> <td>18</td> <td>Drug development and review</td> <td><p>Cooper, Bloom, and Roth. &quot;Treating Neurological and Psychiatric Diseases.&quot; Chapter 13, pp. 373-400.</p> <p>*** Wurtman, R. J., and R. L. Bettiker. &quot;The Slowing of Treatment Discovery, 1965-1995.&quot; <em>Nat Med</em> 1, no. 11 (1995): 1122-1125.</p> <p>*** Wurtman, R. J. &quot;What Went Right: Why is HIV a Treatable Infection?&quot; <em>Nat Med</em> 3, no. 7 (1997): 714-717.</p></td> </tr> <tr class=\"alt-row\"> <td>19</td> <td>Hour examination - final</td> <td>&nbsp;</td> </tr> </tbody> </table></div>", 
    "_content_type_license": "text/plain", 
    "_uid": "c34bfc6f94a3b414e5259756e0fb812a", 
    "title": "Readings", 
    "_ac_local_roles": {
        "admin": [
            "Owner"
        ]
    }, 
    "location": "", 
    "_content_type_course_identifier": "text/plain", 
    "_atbrefs": {
        "isReferencing": [
            "c34bfc6f94a3b414e5259756e0fb812a"
        ]
    }, 
    "constrainTypesMode": 0, 
    "technical_location": "https://ocw.mit.edu/courses/brain-and-cognitive-sciences/9-15-biochemistry-and-pharmacology-of-synaptic-transmission-fall-2007/readings", 
    "software_requirements": [
        {
            "software_type_col": "Browser", 
            "minimum_version_col": "40.0", 
            "software_name_col": "Chrome", 
            "maximum_version_col": ""
        }, 
        {
            "software_type_col": "Browser", 
            "minimum_version_col": "8.0", 
            "software_name_col": "Safari", 
            "maximum_version_col": ""
        }, 
        {
            "software_type_col": "Browser", 
            "minimum_version_col": "38.0", 
            "software_name_col": "Mozilla Firefox", 
            "maximum_version_col": ""
        }, 
        {
            "software_type_col": "Browser", 
            "minimum_version_col": "9.0", 
            "software_name_col": "Internet Explorer", 
            "maximum_version_col": ""
        }, 
        {
            "software_type_col": "Browser", 
            "minimum_version_col": "13.1", 
            "software_name_col": "Edge", 
            "maximum_version_col": ""
        }
    ], 
    "_content_type_technical_location": "text/plain", 
    "_content_type_rights": "text/html", 
    "_directly_provided": [
        "Products.CMFEditions.interfaces.IVersioned"
    ], 
    "parent_uid": "16197636c270e1ab179fbc9a56c72787", 
    "excludeFromNav": false, 
    "_content_type_unique_identifier": "text/plain", 
    "allowDiscussion": false, 
    "metadata_contributor_list": [], 
    "locallyAllowedTypes": [
        "OCWImage", 
        "CourseSection", 
        "OCWExtFile", 
        "OCWFile"
    ], 
    "_content_type_text": "text/html", 
    "ad_type": "HOUSE", 
    "creation_date": "2010/05/14 07:42:21.017 GMT-4", 
    "aggregationlevel": 3, 
    "duration": "", 
    "immediatelyAddableTypes": [
        "OCWImage", 
        "CourseSection", 
        "OCWExtFile", 
        "OCWFile"
    ], 
    "subject": [], 
    "_content_type_short_page_title": "text/plain", 
    "effectiveDate": "None", 
    "parent_module": "16197636c270e1ab179fbc9a56c72787", 
    "is_mathml_document": false, 
    "bottomtext": "", 
    "short_page_title": "Readings", 
    "section_identifier": null, 
    "related_mit_links": "", 
    "_content_type_ad_type": "text/plain", 
    "_layout": "custom_view", 
    "_workflow_history": {
        "page_workflow": [
            {
                "action": null, 
                "review_state": "waiting_for_authoring", 
                "comments": "", 
                "actor": "admin", 
                "time": "2010/05/14 07:42:21.022 GMT-4"
            }, 
            {
                "action": "approve_to_staging", 
                "review_state": "ready_for_staging", 
                "actor": "admin", 
                "comments": "", 
                "time": "2010/05/16 11:30:40.289 GMT-4"
            }
        ]
    }, 
    "_classname": "CourseSection", 
    "_content_type_materialtype": "text/plain", 
    "_userdefined_roles": [], 
    "publisher": "MIT OpenCourseWare", 
    "nextPreviousEnabled": false, 
    "language": "", 
    "url_rewrite_patterns": [], 
    "widgets_features": [], 
    "category_features": [], 
    "firstTimeEdit": true, 
    "feature_requirements": [], 
    "list_in_left_nav": false, 
    "short_name_tlp": "Readings", 
    "expirationDate": "None", 
    "_content_type_id": "text/plain", 
    "contributor_list": [
        {}
    ], 
    "is_media_gallery": false, 
    "contributors": [], 
    "_gopip": 4, 
    "_content_type_title": "text/plain", 
    "course_linking": [], 
    "_atrefs": {
        "BelongsTo": [
            "16197636c270e1ab179fbc9a56c72787"
        ], 
        "isReferencing": [
            "c34bfc6f94a3b414e5259756e0fb812a"
        ]
    }, 
    "other_platform_requirements": "", 
    "license": "http://creativecommons.org/licenses/by-nc-sa/3.0/us/", 
    "rights": "This site (c) Massachusetts Institute of Technology 2010.  Content within individual courses is (c) by the individual authors unless otherwise noted. The Massachusetts Institute of Technology is providing this Work (as defined below) under the terms of this Creative Commons public license (\"CCPL\" or \"license\") unless otherwise noted. The Work is protected by copyright and/or other applicable law. Any use of the work other than as authorized under this license is prohibited. By exercising any of the rights to the Work provided here, You (as defined below) accept and agree to be bound by the terms of this license. The Licensor, the Massachusetts Institute of Technology, grants You the rights contained here in consideration of Your acceptance of such terms and conditions.", 
    "hide_Page_title": null, 
    "_defaultpage": "", 
    "tcATmit_subject_tags": [], 
    "features_tracking": [], 
    "ad_champion_text": "", 
    "has_inline_embed": false, 
    "unique_identifier": "https://ocw.mit.edu/courses/brain-and-cognitive-sciences/9-15-biochemistry-and-pharmacology-of-synaptic-transmission-fall-2007/readings", 
    "is_image_gallery": false, 
    "id": "readings", 
    "materialtype": "Other", 
    "_type": "CourseSection", 
    "description": "This section provides details on the required text for the course and the schedule of assigned readings by session and topic.", 
    "course_identifier": "https://ocw.mit.edu/courses/brain-and-cognitive-sciences/9-15-biochemistry-and-pharmacology-of-synaptic-transmission-fall-2007", 
    "_content_type_publisher": "text/plain", 
    "tcATmit_instructional_tags": [], 
    "_content_type": "text/html", 
    "creators": [
        "admin"
    ], 
    "modification_date": "2017/03/28 15:23:34.403 GMT-4", 
    "always_publish": false, 
    "_content_type_description": "text/plain", 
    "_owner": "admin", 
    "_permissions": {
        "Change portal events": {
            "acquire": false, 
            "roles": [
                "Editor", 
                "Manager", 
                "MetadataEditor", 
                "Owner"
            ]
        }, 
        "Modify portal content": {
            "acquire": false, 
            "roles": [
                "Manager", 
                "MetadataEditor"
            ]
        }, 
        "Access contents information": {
            "acquire": false, 
            "roles": [
                "Authenticated"
            ]
        }, 
        "List folder contents": {
            "acquire": false, 
            "roles": [
                "Editor", 
                "Manager", 
                "MetadataEditor", 
                "Owner"
            ]
        }, 
        "View": {
            "acquire": false, 
            "roles": [
                "Authenticated"
            ]
        }
    }, 
    "_properties": [
        [
            "title", 
            "Readings", 
            "string"
        ]
    ], 
    "_id": "readings", 
    "courselist_features": [], 
    "_content_type_short_name_tlp": "text/plain", 
    "_path": "/Plone/courses/brain-and-cognitive-sciences/9-15-biochemistry-and-pharmacology-of-synaptic-transmission-fall-2007/readings"
}